RA Capital Management - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 103 filers reported holding DYNE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
RA Capital Management ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$19,271,000
-28.7%
2,805,0450.0%0.51%
-12.9%
Q1 2022$27,041,000
-18.9%
2,805,0450.0%0.59%
+0.3%
Q4 2021$33,352,000
-26.8%
2,805,0450.0%0.59%
-6.8%
Q3 2021$45,554,000
-22.8%
2,805,0450.0%0.63%
-33.4%
Q2 2021$59,018,000
+35.5%
2,805,0450.0%0.95%
+44.1%
Q1 2021$43,562,000
-26.0%
2,805,0450.0%0.66%
-20.2%
Q4 2020$58,906,000
+4.0%
2,805,0450.0%0.82%
-20.6%
Q3 2020$56,634,0002,805,0451.04%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,220,034$19,891,50530.79%
MPM ASSET MANAGEMENT LLC 4,951,303$44,363,67523.76%
Atlas Venture Life Science Advisors, LLC 9,885,449$88,573,62313.72%
Logos Global Management LP 2,180,000$19,532,8002.61%
TCG Crossover Management, LLC 1,650,150$14,785,3442.18%
VR Adviser, LLC 2,173,913$19,478,2602.05%
Altium Capital Management LP 315,000$2,822,4001.47%
Vivo Capital, LLC 1,035,136$9,274,8191.02%
Octagon Capital Advisors LP 692,945$6,208,7870.95%
ACUTA CAPITAL PARTNERS, LLC 146,500$1,312,6400.88%
View complete list of DYNE THERAPEUTICS INC shareholders